BioNTech SE BNTX
NASDAQ BNTX
$98.30 -0.27 (-0.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Current Deferred Tax Assets (2020 - 2022)

Updated

BioNTech SE's Current Deferred Tax Assets came in at $73.6 million for Q3 2022, down 8.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Current Deferred Tax Assets (2020 - 2022) Analysis & Trends

At the end of FY2021, BioNTech SE's Current Deferred Tax Assets was $55.48 million, up 73.5% from FY2020.

  • Going back by year, Current Deferred Tax Assets was $31.97 million in FY2020.
  • The five-year range for quarterly Current Deferred Tax Assets is $33.38 million (Q4 2020) to $90.57 million (Q1 2022).
  • Business Quant data shows BNTX's Current Deferred Tax Assets at $80.67 million (Q2 2022), $90.57 million (Q1 2022) and $55.48 million (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioNTech SE 24.86 Bn -34.51 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 73.60 Mn
Jun 30, 2022 80.67 Mn
Mar 31, 2022 90.57 Mn
Dec 31, 2021 55.48 Mn
Dec 31, 2020 33.38 Mn
API Access

BioNTech SE Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BNTX&period=max&api_key=YOUR_API_KEY